• David Blum, Ola Magne Vagnildhaug, Guro Birgitte Stene, Matthew Maddocks, Jonas Sørensen, LairdBarry J ABJA0000-0002-2807-6192Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, United Kingdom., Carla M Prado, Skeidsvoll SolheimToraTCancer Clinic, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.Faculty of Medicine and Health Sciences, Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, N, Jann Arends, Jane Hopkinson, Christopher A Jones, and Mathias Schlögl.
• Competence Center for Palliative Care, Department of Radiation Oncology, University Hospital Zurich, and University of Zurich UZH, Zurich, Switzerland.
• J Palliat Med. 2023 Aug 1; 26 (8): 113311381133-1138.

AbstractCachexia is a multifactorial syndrome that is common in cancer and chronic disease. It is often underdiagnosed and therefore goes untreated or undertreated. Cachexia causes suffering across biopsychosocial domains and affects patients and their loved ones. In this article, a group of clinicians and researchers across cancer care, nutrition, and exercise offers tips about assessment, classification, and management of cachexia, with attention to its stage. The required multimodal management of cachexia mirrors well the interprofessional collaboration that is the mainstay of interdisciplinary palliative care and attention to screening, diagnosis, and management of cachexia is critical to maximize patients' quality of life.

15 keywords...

hide…